Other Controls and Reagents
Medchemexpress LLC DLin-K-C3-DMA | 1217306-46-1 | 98.6% | C44H81NO2 | 1 ML
DLin-K-C3-DMA is a cationic lipid used in the synthesis of nucleic acid-lipid particles for the delivery of nucleic acids. It is intended for research use only.
- Cationic lipid for nucleic acid delivery
- Appearance: colorless to light yellow liquid
- Molecular weight: 656.12
- Supplied as a 10 mM solution
![eMolecules Broadpharm / 181 TAP (DOTAP MS Salt) / 10mg / 718091881 / BP-28291 / 95.000 / 144189-73-1 / [null] / 663.104 / C42H80NO4](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502469549.JPG-250.jpg)
eMolecules Broadpharm / 181 TAP (DOTAP MS Salt) / 10mg / 718091881 / BP-28291 / 95.000 / 144189-73-1 / [null] / 663.104 / C42H80NO4
Broadpharm / 181 TAP (DOTAP MS Salt) / 10mg / 718091881 / BP-28291 / 95.000 / 144189-73-1 / [null] / 663.104 / C42H80NO4
eMolecules BP Lipid 219 | Broadpharm |780.317 | C49H97NO5 | 95.000 | CCCCCCCCC(CCCCCC)C(=O)OCCCCCCCN(CCCO)CCCCCCCOC(=O)C(CCCCCC)CCCCCCCC | 50mg | 698442981
BP Lipid 219 | Broadpharm |780.317 | C49H97NO5 | 95.000 | CCCCCCCCC(CCCCCC)C(=O)OCCCCCCCN(CCCO)CCCCCCCOC(=O)C(CCCCCC)CCCCCCCC | 50mg | 698442981
Cayman Chemical 1 2-DIoleoyl-sn-glycerol 50mg
An analog of the PKC-activating second messengers collectively called DAG; equipotent to 1,2-dioctanoyl-sn-glycerol in induction of the acrosome reaction in human sperm
Avanti Polar Lipids 1-PALMITOYL-2-LINOLEOYL-SN-GLY
1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine | Purity: >99% | Mol Wt: 758.060 | 159701-21-0 | 25mg
Avanti Polar Lipids 18:0 PEG2 PE IN POWDER,1G18:0
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt). 474922-77-5
Avanti Polar Lipids 17:0 cholesteryl ester | 24365-37-5 | MFCD00056438 | 1 mg
17:0 cholesteryl ester | Mol Wt: 639.098 | 24365-37-5 | MFCD00056438 | 1 mg
Avanti Polar Lipids Hexadecyl Coenzyme A (ammonium salt), 71425-89-3, 5 mg
Molecular Formula: C37H77N10O16P3S, Formula Weight: 1042.445, Purity >99%.
Medchemexpress LLC Dspe-peg2000-crgdkgpdc (disulfide bridge:Cys1-Cys9) | 95.0% | 2000 (Average) | 25 MG
DSPE-PEG2000-iRGD is a PEG compound composed of DSPE and an αv-integrins targeting peptide (iRGD). The iRGD peptide binds to αv-integrins and is then proteolytically cleaved in the tumor to produce CRGDK/R, which interacts with neuropilin-1. This compound has tumor-targeting and tumor-penetrating properties and can be used for agent delivery.
- Irgd peptide binds to αv-integrins.
- Proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin-1.
- Possesses tumor-targeting and tumor-penetrating properties.
- Can be used for agent delivery.
- Used to construct nanomicelles for targeted delivery of salinomycin to intervene in liver cancer cells and cancer stem cells.
- Used to construct a tumor-penetrating peptide liposome that exhibits antitumor effects, including a significant reduction in tumor volume and an increase in body weight and spleen index.